PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

37 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Goldberg, D.T.* et al.: Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes; the DIRECT PLUS clinical trial. Hepatology, DOI: 10.1097/HEP.0000000000000867 (2024)
2.
De Angelis Rigotti, F.* et al.: Semaphorin 3C exacerbates liver fibrosis. Hepatology 78, 1092-1105 (2023)
3.
Lenz, D.* et al.: Genetic landscape of pediatric acute liver failure of indeterminate origin. Hepatology 79, 1075-1087 (2023)
4.
Lichtmannegger, J. et al.: ARBM-101 as a potential therapeutic for wilson disease. Hepatology 76, S135-S136 (2022)
5.
Subramanian, P.* et al.: The RNA binding protein HuR is a gatekeeper of liver homeostasis. Hepatology 75, 881-897 (2022)
6.
Barahona Ponce, C.* et al.: Gallstones, body mass index, C-reactive protein and gallbladder cancer—Mendelian randomization analysis of chilean and European genotype data. Hepatology 73, 1783-1796 (2021)
7.
Brägelmann, J.* et al.: Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology 73, 2293-2310 (2021)
8.
Riedl, T.* et al.: HIF1α-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence. Hepatology 74, 1766-1781 (2021)
9.
Kosinska, A. ; Kallin, A.* ; Protzer, U. & Knolle, P.A.*: Overcoming liver tolerance to clear persistent HBV infection. Hepatology 68, 334A-334A (2018)
10.
Manske, K.* et al.: Outcome of antiviral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes. Hepatology 68, 2089-2105 (2018)
11.
Michler, T. et al.: Suppression of hepatitis B virus antigens by RNA interference enables therapeutic vaccination to achieve immune control in high-titer virus carriers. Hepatology 68, 49A-50A (2018)
12.
von Loeffelholz, C.* & Birkenfeld, A.L.: Reply. Hepatology 67, 452-453 (2018)
13.
von Loeffelholz, C.* et al.: The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism. Hepatology 66, 616-630 (2017)
14.
Zhang, W.* et al.: PRMT5 restricts hepatitis B virus replication via epigenetic repression of cccDNA transcription and interference with pgRNA encapsidation. Hepatology 66, 398-415 (2017)
15.
Koppe, C.* et al.: IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64, 1217-1231 (2016)
16.
Koppe, C.* et al.: A new molecular interaction between IKK alpha/beta and RIPK1 regulates biliary homeostasis and hepatocarcinogenesis. Hepatology 63, 1, 257A-258A (2016)
17.
Li, Y.* et al.: IFN-alpha-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection. Hepatology 63, 1, 921A-921A (2016)
18.
Matter, M.S.* et al.: Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology 63, 1888-1899 (2016)
19.
Sunami, Y.* et al.: Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
20.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮